Pharmacodynamics of recombinant human DNASE I in serum

Clinical and Experimental Immunology

Volumn 113, Issue 2, 1998, Pages 289-296

  Prince, W S ^a   Baker, D L ^a   Dodge, A H ^a   Ahmed, A E ^b   Chestnut, R W ^a   Sinicropi, D V ^a  

^a GENENTECH INC   (United States)

^b Specialty Laboratories   (United States)

Author keywords

DNA chromatin; DNase I; Enzyme assays; Immune complexes; Systemic lupus erythematosus

Indexed keywords

DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASE INHIBITOR; DORNASE ALFA; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN CONDENSATION; DOSE RESPONSE; DRUG POTENCY; ENZYME ANALYSIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; IMMUNE COMPLEX DISEASE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; BLOOD; CHROMATIN; DEOXYRIBONUCLEASE I; DNA; DNA, VIRAL; ENZYME INHIBITORS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECOMBINANT PROTEINS;

EID: 0031924931     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00647.x     Document Type: Article

References (33)

1. Klippel JH, Decker JL. Systemic lupus erythematosus. In: Zvaifler NJ, ed. Internal medicine. Boston: Little, Brown & Co., 1990:1739-46.
2. Lefkowith JB, Kiehl M, Rubenstein J et al. Heterogeneity and clinical significance of glomerular-hinding antibodies in SLE. J Clin Invest 1996 98:1373-80.
3. Lefkowith JB, Gilkeson GS. Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. Arthritis Rheum 1996 39:894-903.
4. terBorg EJ, Horst G, Hummel EJ et al. Measurement of increases in anti-double stranded DNA antibody levels as a predictor of disease exacerbation in SLE. Arthritis Rheum 1990 33:634-42.
5. Yamada A, Miyakawa Y, Kosaka K. Entrapment of anti-DNA antibodies in the kidney of patients with systemic lupus erythematosus. Kidney Int 1982 22:671-6.
6. Koffler D, Agnello V, Kunkel HG. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. Am J. Pathol 1973 74:109-24.
7. Sasaki T, Muryoi T, Hatakeyama A et al. Circulating anti-DNA immune complexes in active lupus nephritis. Am J Med 1991 91:355-62.
8. Malide D, Londono I, Russo P et al. Ultrastructural localization of DNA in immune deposits of human lupus nephritis. Am J Pathol 1993 143:304-11.
9. Kramers C, Hylkema MN, Vanbruggen MC et al. Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membranes in vivo. J Clin Invest 1994 94:568-77.
10. Raz E, Brezis M, Rosenmann E et al. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol 1989 142:3076-82.
11. Klinman DM, Shirai A, Ishigatsuho Y et al. Quantitation of IgM and IgG-secreting B cells in the peripheral blood of patients with SLE. Arthritis Rheum 1991 34:1404-10.
12. 1 hybrids, but not in normal mice. Eur J Immunol 1994 24:66-70.
13. Gilkeson GS, Pippen AM, Pisetsky DS. Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/W mice by immunization with bacterial DNA. J Clin Invest 1995 95:1398-402.
14. Lachmann PJ. Allergic reactions, connective tissue and disease. The Scientific Basis of Medicine Annual Reviews 1967. London: British Postgraduate Medical Federation, University of London, The Athlone Press, 1967:35-58.
15. 1 hybrid mice: studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol 1996 106:243-52.
16. Lachmann PJ. The in vivo destruction of antigen - a tool for probing and modulating an autoimmune response. Clin Exp Immunol 1996 106:187-9.
17. Kunitz M. Crystalline desoxyribonuclease I: isolation and general properties. J Gen Physiol 1950 33:349-62.
18. Sinicropi D, Baker DL, Prince WS et al. Colorimetric determination of DNase I activity with a DNA-methyl green substrate. Anal Biochem 1994 222:351-8.
19. Morgan AR, Evans DH, Lee JS et al. Ethidium fluorescence assay. Part II. Enzymatic studies and DNA-protein interactions. Nucelic Acids Res 1979 7:571-97.
20. Marquardt DW. An algorithm for least squares estimation of nonlinear parameters. J Soc Ind Appl Math 1963 11:413-41.
21. Smeenk R, Hylkema M. Detection of antibodies to DNA: a technical assessment. Mol Bio Rep 1992 17:71-79.
22. 4 procedure. Methods Cell Biol 1990; 33:363-7.
23. Kissane JM, Robins E. The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system. J Biol Chem 1958 233:184-8.
24. Pan CQ, Lazarus RA. Engineering hyperactive variants of human deoxyribonuclease I by altering its functional mechanism. Biochemistry 1997 36:6624-32.
25. Mohler M, Cook J, Lewis D et al. Altered pharmacokinetics of recombinant human deoxyribonuclease in rats due to the presence of a binding protein. Drug Metab Dispos 1993 21:71-75.
26. Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci USA 1974 71:4742-6.
27. Macanovic M, Lachmann PJ. Measurement of deoxyribonuclease I (DNase) in the serum and urine of systemic lupus erythemutosus (SLE)-prone NZB/NZW mice by a new radial enzyme diffusion assay. Clin Exp Immunol 1997 108:220-6.
28. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus-occurrence as multimeric complexes bound to histone. J Clin Invest 1990 86:69-74.
29. Studitsky VM, Clark DJ, Felsenfeld G. A histone octamer can step around a transcribing polymerase without leaving the template. Cell 1994 76:371-82.
30. Lewin B. Chromatin and gene expression: constant questions, but changing answers. Cell 1994 79:397-406.
31. 2 system. J Rheumatol 1995 22: 1075-85.
32. Emlen W, Ansari R, Burdick G. DNA/anti-DNA immune complexes: antibody protection of a discrete DNA fragment from DNase digestion in vitro. Clin Invest 1984 74:185-90.
33. Ulmer JS, Herzka A, Toy K et al. Engineering actin-resistant human DNase I for treatment of cystic fibrosis. Proc Natl Acad Sci USA 1996 93:8225-9.